| Mrs Marleah Mcanalley, CRNP | |
|
700 W Market St, Athens, AL 35611-2457 | |
| (256) 233-9292 | |
| (256) 233-9272 |
| Full Name | Mrs Marleah Mcanalley |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 700 W Market St, Athens, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104195015 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1-052209 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Health Care Clinic Inc | 5395656946 | 38 |
News Archive
Octapharma confirmed today the European Medicines Agency (EMA) has adopted a positive opinion towards human cell line recombinant human FVIII, Nuwiq®, recommending the granting of a marketing authorisation for the medicinal product for treatment and prophylaxis of bleeding (also during and after surgery) in paediatric and adult patients with haemophilia A (congenital FVIII deficiency).
Even as federal officials push states to expand Medicaid programs, at least a dozen states are not ready or not willing to set up state-based health exchanges - another aspect of the health law that is key to expanding insurance coverage.
Led by Drs John Postlethwait and Ingo Braasch from the Institute of Neuroscience, University of Oregon, US, in collaboration with the Broad Institute, the study of the Spotted Gar (Lepisosteus oculatus) genome reveals that it is small and manageable. Furthermore, it lacks much shuffling and duplication that occurred in the 'main' fish ancestral line; it conserved its genome.
Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
› Verified 4 days ago
| Entity Name | Limestone Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841266434 PECOS PAC ID: 9739102393 Enrollment ID: O20060110000160 |
News Archive
Octapharma confirmed today the European Medicines Agency (EMA) has adopted a positive opinion towards human cell line recombinant human FVIII, Nuwiq®, recommending the granting of a marketing authorisation for the medicinal product for treatment and prophylaxis of bleeding (also during and after surgery) in paediatric and adult patients with haemophilia A (congenital FVIII deficiency).
Even as federal officials push states to expand Medicaid programs, at least a dozen states are not ready or not willing to set up state-based health exchanges - another aspect of the health law that is key to expanding insurance coverage.
Led by Drs John Postlethwait and Ingo Braasch from the Institute of Neuroscience, University of Oregon, US, in collaboration with the Broad Institute, the study of the Spotted Gar (Lepisosteus oculatus) genome reveals that it is small and manageable. Furthermore, it lacks much shuffling and duplication that occurred in the 'main' fish ancestral line; it conserved its genome.
Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
› Verified 4 days ago
| Entity Name | Family Health Care Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184857195 PECOS PAC ID: 5395656946 Enrollment ID: O20100628001034 |
News Archive
Octapharma confirmed today the European Medicines Agency (EMA) has adopted a positive opinion towards human cell line recombinant human FVIII, Nuwiq®, recommending the granting of a marketing authorisation for the medicinal product for treatment and prophylaxis of bleeding (also during and after surgery) in paediatric and adult patients with haemophilia A (congenital FVIII deficiency).
Even as federal officials push states to expand Medicaid programs, at least a dozen states are not ready or not willing to set up state-based health exchanges - another aspect of the health law that is key to expanding insurance coverage.
Led by Drs John Postlethwait and Ingo Braasch from the Institute of Neuroscience, University of Oregon, US, in collaboration with the Broad Institute, the study of the Spotted Gar (Lepisosteus oculatus) genome reveals that it is small and manageable. Furthermore, it lacks much shuffling and duplication that occurred in the 'main' fish ancestral line; it conserved its genome.
Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
› Verified 4 days ago
| Entity Name | Athens Limestone Pain Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689063851 PECOS PAC ID: 3072830769 Enrollment ID: O20150317001609 |
News Archive
Octapharma confirmed today the European Medicines Agency (EMA) has adopted a positive opinion towards human cell line recombinant human FVIII, Nuwiq®, recommending the granting of a marketing authorisation for the medicinal product for treatment and prophylaxis of bleeding (also during and after surgery) in paediatric and adult patients with haemophilia A (congenital FVIII deficiency).
Even as federal officials push states to expand Medicaid programs, at least a dozen states are not ready or not willing to set up state-based health exchanges - another aspect of the health law that is key to expanding insurance coverage.
Led by Drs John Postlethwait and Ingo Braasch from the Institute of Neuroscience, University of Oregon, US, in collaboration with the Broad Institute, the study of the Spotted Gar (Lepisosteus oculatus) genome reveals that it is small and manageable. Furthermore, it lacks much shuffling and duplication that occurred in the 'main' fish ancestral line; it conserved its genome.
Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Marleah Mcanalley, CRNP 700 W Market St, Athens, AL 35611-2457 Ph: (256) 233-9292 | Mrs Marleah Mcanalley, CRNP 700 W Market St, Athens, AL 35611-2457 Ph: (256) 233-9292 |
News Archive
Octapharma confirmed today the European Medicines Agency (EMA) has adopted a positive opinion towards human cell line recombinant human FVIII, Nuwiq®, recommending the granting of a marketing authorisation for the medicinal product for treatment and prophylaxis of bleeding (also during and after surgery) in paediatric and adult patients with haemophilia A (congenital FVIII deficiency).
Even as federal officials push states to expand Medicaid programs, at least a dozen states are not ready or not willing to set up state-based health exchanges - another aspect of the health law that is key to expanding insurance coverage.
Led by Drs John Postlethwait and Ingo Braasch from the Institute of Neuroscience, University of Oregon, US, in collaboration with the Broad Institute, the study of the Spotted Gar (Lepisosteus oculatus) genome reveals that it is small and manageable. Furthermore, it lacks much shuffling and duplication that occurred in the 'main' fish ancestral line; it conserved its genome.
Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
› Verified 4 days ago
Zachary Andrew Curtis, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 700 W Market St, Athens, AL 35611 Phone: 256-233-9292 | |
Marla Renee Mcclure, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 12100 Two Rivers Dr Apt J-1, Athens, AL 35611 Phone: 564-600-2472 | |
Anne Tate Wilson, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 101 Fitness Way, Suite 1200, Athens, AL 35611 Phone: 256-232-0636 Fax: 256-232-1281 | |
Lindsay Traynom, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22454 Us Highway 72 Ste 200, Athens, AL 35613 Phone: 256-233-2332 | |
Diane Goodman Waits, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 700 W Market St, Athens, AL 35611 Phone: 800-893-9698 | |
April Seay, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7715 Us Highway 72, Athens, AL 35611 Phone: 256-729-9477 | |
Christina C Vail, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 700 W Market St, Athens, AL 35611 Phone: 256-233-9292 |